IMPORT-201 (IMP-MEL): A Phase 1 first-in-human dose finding/randomized Phase 2 study of a novel iNKT agonist (PORT-2) and pembrolizumab for advanced melanoma and non-small cell lung cancer (NSCLC)
Pembrolizumab;PORT-2
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: IMPORT-201 (IMP-MEL): A Phase 1 first-in-human dose finding/randomized Phase 2 study of a novel iNKT agonist (PORT-2) and pembrolizumab for advanced melanoma and non-small cell lung cancer (NSCLC) ### Output: Pembrolizumab;PORT-2